Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is the timing of chemotherapy important in patients undergoing preoperative radiotherapy for rectal cancer?

Nature Clinical Practice Oncology volume 4, pages 150–151 (2007)Cite this article

boxed-textBosset J-F et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355: 1114–1123

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kapitejn E et al. (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 639–646

    Google Scholar 

  2. Sauer R et al. (2004) German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731–1740

    Article  Google Scholar 

  3. Bujko K et al. (2006) Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93: 1215–1223

    Article  Google Scholar 

  4. Gerard JP et al. (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancers: results of FFCD 9203. J Clin Oncol 24: 4620–4625

    Article  Google Scholar 

  5. Cionini L et al. (2001) Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC): preliminary results [abstract]. Eur J Cancer 37: a1107

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Centre for Cancer Treatment, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK rob.glynnejones@nhs.net

Authors and Affiliations

  1. R Glynne-Jones is Consultant Clinical Oncologist at Mount Vernon Cancer Centre, Northwood, UK.,

    Robert Glynne-Jones

Authors
  1. Robert Glynne-Jones
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

R Glynne-Jones has sat on advisory boards for Pfizer, Merck, Sanofi-Aventis, Roche and AstraZeneca, and has been funded to go to international meetings in the past two years by Sanofi-Aventis, Merck and Roche. R Glynne-Jones has no other appointments, directorships or honorary appointments that might give rise to conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glynne-Jones, R. Is the timing of chemotherapy important in patients undergoing preoperative radiotherapy for rectal cancer?. Nat Rev Clin Oncol 4, 150–151 (2007). https://doi.org/10.1038/ncponc0741

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncponc0741

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing